PCN130 Dose-Dependent Relation between Metformin and the Risk of Hormone Receptor-Positive, HER2-Negative (HR+/HER2-) Breast Cancer Among Postmenopausal Women with Type-2 DiabetesSoumya Chikermane, Magnus L. Johnson, Rajender R. Aparasu et al.|Value in Health|2021Cited by 0